4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001209191-22-031498
Chief Business Officer acquired 16,224 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Hannah Brendan · Chief Business Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-05-19 | Grant or award : show line 1 in the form | +16,224 | 16,224 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-05-19 | Grant or award : show line 2 in the form Employee Stock Option (right to buy) | +103,500 | 103,500 | D |
| 2022-05-23 | Grant or award : show line 3 in the form Employee Stock Option (right to buy) | +353,656 | 353,656 | D |
Loading xslF345X03/doc4.xml…